BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29984641)

  • 1. Molecular Aspects of the Dengue Virus Infection Process: A Review.
    Zonetti LFC; Coutinho MC; de Araujo AS
    Protein Pept Lett; 2018; 25(8):712-719. PubMed ID: 29984641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid changes within the E protein hinge region that affect dengue virus type 2 infectivity and fusion.
    Butrapet S; Childers T; Moss KJ; Erb SM; Luy BE; Calvert AE; Blair CD; Roehrig JT; Huang CY
    Virology; 2011 Apr; 413(1):118-27. PubMed ID: 21353281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of endosomal-membrane association for the dengue virus envelope protein.
    Rogers DM; Kent MS; Rempe SB
    Biochim Biophys Acta; 2015 Apr; 1848(4):1041-52. PubMed ID: 25559317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Potent Inhibitors for the Inhibition of Dengue Envelope Protein: An In Silico Approach.
    Aarthy M; Singh SK
    Curr Top Med Chem; 2018; 18(18):1585-1602. PubMed ID: 30360716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes.
    Erb SM; Butrapet S; Moss KJ; Luy BE; Childers T; Calvert AE; Silengo SJ; Roehrig JT; Huang CY; Blair CD
    Virology; 2010 Oct; 406(2):328-35. PubMed ID: 20708768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors and routes of dengue virus entry into the host cells.
    Cruz-Oliveira C; Freire JM; Conceição TM; Higa LM; Castanho MA; Da Poian AT
    FEMS Microbiol Rev; 2015 Mar; 39(2):155-70. PubMed ID: 25725010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
    Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
    Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavivirus cell entry and membrane fusion.
    Smit JM; Moesker B; Rodenhuis-Zybert I; Wilschut J
    Viruses; 2011 Feb; 3(2):160-171. PubMed ID: 22049308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the dengue virus envelope protein after membrane fusion.
    Modis Y; Ogata S; Clements D; Harrison SC
    Nature; 2004 Jan; 427(6972):313-9. PubMed ID: 14737159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel flavanone derivative inhibits dengue virus fusion and infectivity.
    Srivarangkul P; Yuttithamnon W; Suroengrit A; Pankaew S; Hengphasatporn K; Rungrotmongkol T; Phuwapraisirisan P; Ruxrungtham K; Boonyasuppayakorn S
    Antiviral Res; 2018 Mar; 151():27-38. PubMed ID: 29360474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation.
    Zhang Q; Hunke C; Yau YH; Seow V; Lee S; Tanner LB; Guan XL; Wenk MR; Fibriansah G; Chew PL; Kukkaro P; Biukovic G; Shi PY; Shochat SG; Grüber G; Lok SM
    J Biol Chem; 2012 Nov; 287(48):40525-34. PubMed ID: 23035113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the identification of dengue virus entry/fusion inhibitors.
    De La Guardia C; Lleonart R
    Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small molecule fusion inhibitor of dengue virus.
    Poh MK; Yip A; Zhang S; Priestle JP; Ma NL; Smit JM; Wilschut J; Shi PY; Wenk MR; Schul W
    Antiviral Res; 2009 Dec; 84(3):260-6. PubMed ID: 19800368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein.
    Lee E; Weir RC; Dalgarno L
    Virology; 1997 Jun; 232(2):281-90. PubMed ID: 9191841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry.
    Chin JF; Chu JJ; Ng ML
    Microbes Infect; 2007 Jan; 9(1):1-6. PubMed ID: 17196419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide inhibitors of flavivirus entry derived from the E protein stem.
    Schmidt AG; Yang PL; Harrison SC
    J Virol; 2010 Dec; 84(24):12549-54. PubMed ID: 20881042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of prohibitin as a receptor protein mediating DENV-2 entry into insect cells.
    Kuadkitkan A; Wikan N; Fongsaran C; Smith DR
    Virology; 2010 Oct; 406(1):149-61. PubMed ID: 20674955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pushing the Envelope: Dengue Viral Membrane Coaxed into Shape by Molecular Simulations.
    Marzinek JK; Holdbrook DA; Huber RG; Verma C; Bond PJ
    Structure; 2016 Aug; 24(8):1410-1420. PubMed ID: 27396828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface proteins of C6/36 cells involved in dengue virus 4 binding and entry.
    Vega-Almeida TO; Salas-Benito M; De Nova-Ocampo MA; Del Angel RM; Salas-Benito JS
    Arch Virol; 2013 Jun; 158(6):1189-207. PubMed ID: 23344777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive structural change of the envelope protein of dengue virus induced by a tuned ionic strength: conformational and energetic analyses.
    Degrève L; Fuzo CA; Caliri A
    J Comput Aided Mol Des; 2012 Dec; 26(12):1311-25. PubMed ID: 23160852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.